Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to -$2000.0.

  • Nephros' Cash from Financing Activities changed N/A to -$2000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5000.0, marking a year-over-year increase of 2857.14%. This contributed to the annual value of -$5000.0 for FY2024, which is 9367.09% up from last year.
  • Latest data reveals that Nephros reported Cash from Financing Activities of -$2000.0 as of Q3 2025.
  • In the past 5 years, Nephros' Cash from Financing Activities ranged from a high of $281000.0 in Q1 2022 and a low of -$111000.0 during Q4 2022
  • Moreover, its 5-year median value for Cash from Financing Activities was -$2000.0 (2023), whereas its average is $10764.7.
  • Data for Nephros' Cash from Financing Activities shows a peak YoY increase of 946666.67% (in 2022) and a maximum YoY decrease of 25000.0% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows Nephros' Cash from Financing Activities stood at -$37000.0 in 2021, then tumbled by 200.0% to -$111000.0 in 2022, then soared by 97.3% to -$3000.0 in 2023, then soared by 66.67% to -$1000.0 in 2024, then crashed by 100.0% to -$2000.0 in 2025.
  • Its Cash from Financing Activities was -$2000.0 in Q3 2025, compared to -$1000.0 in Q2 2025 and -$1000.0 in Q1 2025.